Recent Updates
Recently added Catalysts
ACRS

Aclaris Therapeutics to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference

Key Takeaway: MALVERN, Pa., July 05, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced that Dr. Neal Walker, President & Chief Executive Officer, will present at Cantor Fitzgerald’s 2nd Annual Healthcare Confer

Full Press Release Details

MALVERN, Pa., July 05, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced that Dr. Neal Walker, President & Chief Executive Officer, will present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on Tuesday, July 12, 2016 at 2:30 p.m. Eastern Time. The conference will be held at the Le Parker Meridien Hotel in New York, NY.
A live audio webcast of the Aclaris presentation may be accessed by visiting the “Investors” section of the Company’s website at www.aclaristx.com. A replay of the webcast will be archived on the Aclaris website for 14 days following the presentation date.
Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated drugs to address significant unmet needs in dermatology. Aclaris Therapeutics, Inc. is based in Malvern, Pennsylvania and more information can be found by visiting the company’s website at www.aclaristx.com.

Contact Data

Chief Financial Officer

Contact

With a Reader Account, it's easy to send email directly to the contact for this release. Sign up today for your free Reader Account!
Already have an account? Log in here.
Last updated: Jul 5, 2016